​Asafoetida Gum (Stinking Gum)

Asafoetida Gum (Stinking Gum)

Product Name: Асафетида, Asafoetida, Teufelsdreck, Asafétida, Asa fétida, صمغ الأنجدان, ฮิง, Asafoetida saqich, Asafoetida zamk, Asafoetida saqqyz, Асафетидаи заминӣ, Asafetida, Asafetida, Асафетида, אספטידה

Synonyms: асафетида, ферула вонючая, дьявольский кал, камедь асафетиды, hing, devil’s dung, stinking gum, food of the gods, Asa foetida, Asant, Teufelsdreck, Asafétida, Goma apestosa, Asa fétida, الصمغ النتني, صمغ الكريهة, ฮิง, หิง, หิงคุ์, ยางหิงคุ์, ยางกลิ่นแรง

Parts Used: root, underground rhizome, gum, milky sap, resin

Main Indications for Asafoetida Use: Ulcerative colitis, functional dyspepsia, small intestinal bacterial overgrowth syndrome, parasitic infestations, intestinal colic, viral and bacterial gastroenteritis, bronchospasm, chronic bronchitis, spastic cough, whooping cough, premenstrual syndrome, hypomenorrhea, chronic pelvic pain, asthenoneurotic syndrome, anxiety disorder, nervous excitement, insomnia.

Use of Asafoetida in mixtures and complexes: Irritable bowel syndrome, flatulence, chronic dyspepsia, pancreatic insufficiency, giardia and pinworm infestations, intestinal mycoses, chronic sinusitis, chronic tonsillitis, pharyngitis, oophoritis, adnexitis, climacteric syndrome, autonomic dysfunction, hyperactivity in children.

Pharmacological Properties of Asafoetida: anti-inflammatory, antimicrobial, antiparasitic, spasmolytic, carminative, anthelmintic, bronchodilatory, expectorant, analgesic, sedative, antioxidant, anticonvulsant, immunomodulating, estrogen-like, gastroprotective, anxiolytic.

Dosage of Pharmaceutical Forms — Asafoetida

Powder — Asafoetida

Indications (Powder): Ulcerative colitis, small intestinal bacterial overgrowth syndrome, bacterial gastroenteritis, parasitic infestations, spastic constipation, functional dyspepsia, gastric hyposecretion, chronic bronchitis, whooping cough, premenstrual syndrome, asthenoneurotic syndrome, anxiety disorder.

Standard Dosage (Powder): 100–200 milligrams of powder orally, one to two times a day, 20 minutes before meals, with warm water. Maximum duration of standard intake — 10 days, then a 5-day break.

Enhanced Dosage (Powder): 300 milligrams of powder three times a day in the presence of pronounced symptoms: exacerbation of ulcerative colitis, bacterial gastroenteritis, parasitic infestations, whooping cough in adults. Duration of use — no more than 7 days in a row.

Maximum Dosage (Powder): Up to 500 milligrams of powder three times a day is allowed exclusively under the supervision of a specialist for the treatment of acute bacterial diarrhea, pronounced colicky abdominal pain, giardia enteritis. Maximum duration — 3 days.

Preventive Dosage (Powder): 50–100 milligrams of powder once a day 30 minutes before breakfast. Recommended for patients with irritable bowel syndrome, a tendency to flatulence, chronic giardiasis, women with premenstrual syndrome, persons with chronic anxiety disorder. Preventive course — 21 days, then a 14-day break.

Pediatric Dosage (Powder): From 6 years of age and body weight of at least 25 kilograms — 20–50 milligrams of powder, once a day, after consultation with a physician. For younger children, safety and efficacy have not been established. Dosage is the same for boys and girls.

Contraindications (Powder): Gastritis with hyperacidity, gastric ulcer in the acute stage, epilepsy, pronounced cardiac arrhythmias. No contraindications scientifically registered for pregnancy, lactation and children under 6 years of age — additional clinical studies are required.

Side Effects (Powder): Flatulence, nausea, diarrhea, irritation of the gastric mucosa, headache, feeling of heat in the body — when exceeding the dosage of more than 600 milligrams per day.

Adjustment for Patient Body Weight: For patients with body weight up to 60 kilograms, it is recommended to reduce the dosage by 25%. With body weight over 80 kilograms, an increase in dosage by 25% is possible, not exceeding the maximum daily limit.

Preparation method (Powder): Dry asafoetida gum until brittle at a temperature not exceeding 40 degrees Celsius, avoiding direct sunlight. Grind in a ceramic or glass mortar to a powder state. For stabilization, store with 2 grams of rice flour per 100 grams of product. Package in a glass container with a tightly closing lid.

Storage Conditions and Shelf Life (Powder): Store in a dry, cool place at a temperature of 10 to 25 degrees Celsius, in the dark, in an airtight glass container shielded from electromagnetic radiation. Shelf life — up to 12 months. After opening, use within 60 days.

Dry Extract — Asafoetida

Indications (Dry Extract): Functional dyspepsia, chronic gastritis with low acidity, small intestinal bacterial overgrowth syndrome, flatulence, parasitic infestations, whooping cough, chronic bronchitis, spastic bronchial obstruction, premenstrual syndrome, anxiety disorder, insomnia.

Standard Dosage (Dry Extract): 150–200 milligrams of dry extract orally, once a day, in the afternoon after meals. Take with warm water.

Enhanced Dosage (Dry Extract): 300 milligrams once or twice a day in the presence of persistent flatulence, chronic gastritis with dyspeptic syndrome, whooping cough with pronounced bronchospasm. Course — 5–7 days.

Maximum Dosage (Dry Extract): Up to 400 milligrams of dry extract twice a day for severe forms of parasitic infestations, broncho-obstructive syndrome, anxiety-depressive disorders with autonomic disorders. Duration — no more than 3 days in a row.

Preventive Dosage (Dry Extract): 100 milligrams of dry extract once a day. Prescribed for chronic tendency to flatulence, dysbiosis, premenstrual disorders, mild anxiety. Recommended for patients over 40 years of age, as well as for women in perimenopause. Course — 14 days on / 14 days off.

Pediatric Dosage (Dry Extract): From 7 years of age and body weight of at least 30 kilograms — 50 milligrams of dry extract once a day, course no more than 5 days. Use at a younger age is not recommended due to lack of sufficient data.

Contraindications (Dry Extract): Gastric ulcer, gastritis with hypersecretion, bronchial asthma in the acute stage, epilepsy, organic liver lesions. No reliable data on contraindications during pregnancy, lactation and in children under 7 years of age.

Side Effects (Dry Extract): Nausea, headache, irritability, increased intestinal peristalsis, allergic rash. Observed when taking doses exceeding 500 milligrams per day.

Adjustment for Patient Body Weight: For patients up to 60 kilograms, it is recommended to reduce the dosage by 20%. With body weight over 80 kilograms, an increase in dosage by 20% is permissible, not exceeding 400 milligrams per day.

Preparation method (Dry Extract): Grind 100 grams of asafoetida gum and pour 1 liter of 70% ethanol. Infuse in an airtight glass container for 10 days at a temperature of 20–25 degrees Celsius in the dark. Filter. Evaporate the solution in a water bath at a temperature not exceeding 50 degrees Celsius until a viscous mass forms. Dry in a drying chamber at 40 degrees to obtain a dry residue. Grind the resulting dry extract into powder, add 2 grams of rice starch per 100 grams of finished extract.

Storage Conditions and Shelf Life (Dry Extract): Store in an airtight glass container at a temperature of 10–25 degrees Celsius, in a dry, light-protected place. Avoid storing near electrical appliances. Shelf life — 24 months. After opening, use within 90 days.

Alcohol-Based Tincture — Asafoetida

Indications (Tincture): Functional dyspepsia, intestinal colic, parasitic infestations, chronic gastritis with hyposecretion, spastic constipation, chronic bronchitis, whooping cough, spastic cough, hypomenorrhea, premenstrual syndrome, asthenoneurotic syndrome, anxiety disorder.

Standard Dosage (Tincture): 15 drops of alcohol tincture per 50 milliliters of warm water, 2 times a day 30 minutes before meals.

Enhanced Dosage (Tincture): 20 drops three times a day in the presence of acute intestinal spasms, parasitic infestations, whooping cough, pronounced symptoms of premenstrual syndrome. Course — no more than 5 days in a row.

Maximum Dosage (Tincture): 30 drops 3 times a day in severe cases of whooping cough, bronchospasm, severe intestinal pain, giardiasis. Use no more than 3 days, then a mandatory break.

Preventive Dosage (Tincture): 10 drops once a day in 50 ml of warm water. Indicated for patients with a predisposition to intestinal colic, chronic flatulence, a tendency to anxiety disorders, women with menstrual irregularities. Course — 14 days on / 14 days off.

Pediatric Dosage (Tincture): From 8 years of age, with body weight from 30 kilograms — 5 drops in 30 ml of water once a day. Only as prescribed by a physician. For younger children and under 8 years of age — not used.

Contraindications (Tincture): Liver diseases, alcoholism, epilepsy, gastric ulcer, hyperacid gastritis. Not recommended during pregnancy and breastfeeding. Not used in children under 8 years of age due to ethanol content.

Side Effects (Tincture): Burning pain in the stomach, nausea, dizziness, palpitations, rash. Observed with overdose of more than 100 drops per day.

Adjustment for Patient Body Weight: For patients up to 60 kilograms, a dosage reduction of 25% is recommended. With body weight over 80 kilograms — titration up to 25 drops per dose is possible without exceeding the daily limit.

Preparation method (Tincture): Grind 100 grams of dried asafoetida gum, pour 500 milliliters of 70% ethyl alcohol. Infuse in a glass container with a tightly closing lid for 10 days at a temperature of 20–25 degrees Celsius, in the dark. Shake periodically. After infusion, filter through cheesecloth and store in dark glass.

Storage Conditions and Shelf Life (Tincture): Store in an airtight dark glass container, at a temperature of 10 to 25 degrees Celsius, in a light-protected place, away from sources of heat and electromagnetic radiation. Shelf life — up to 24 months. After opening, use within 90 days.

Oil Infusion — Asafoetida

Indications (Oil Infusion): Flatulence, intestinal spasms, chronic constipation, gastric hyposecretion, parasitic infestations, bronchospasm, spastic cough, chronic bronchitis, hypomenorrhea, premenstrual syndrome, chronic pelvic pain, anxiety disorder, localized abdominal pain in women of reproductive age.

Standard Dosage (Oil Infusion): 1 teaspoon orally once a day during or immediately after meals, for 10 days.

Enhanced Dosage (Oil Infusion): 1 teaspoon twice a day for spastic constipation, pronounced premenstrual pain, chronic bronchitis with cough, acute intestinal colic. Duration of intake — no more than 5 days.

Maximum Dosage (Oil Infusion): 1 tablespoon twice a day is allowed in case of pronounced intestinal spasms, attacks of colic, parasitic infestations. Allowed no more than 3 days in a row.

Preventive Dosage (Oil Infusion): Half a teaspoon (2.5 ml) orally once a day, during meals. Indicated for patients with chronic flatulence, a tendency to spastic constipation, women with regular premenstrual pain syndrome. Course — 21 days, 14-day break.

Pediatric Dosage (Oil Infusion): Permissible from 6 years of age, with body weight from 20 kilograms — 0.5 teaspoon once a day during meals. Only after consultation with a physician. Not recommended for children under 6 years of age.

Contraindications (Oil Infusion): Pancreatitis, cholecystitis in the acute stage, diarrheal syndrome, individual intolerance to essential oils, allergy to spices. No scientific data on the safety of use during pregnancy, lactation and in children under 6 years of age.

Side Effects (Oil Infusion): Nausea, diarrhea, feeling of bitterness, increased bile secretion, heartburn. May occur when exceeding the dosage of more than 30 ml per day.

Adjustment for Patient Body Weight: For patients with body weight up to 60 kilograms, the dosage is reduced by one third (e.g., 2/3 teaspoon). With body weight over 80 kilograms, an increase to a full tablespoon is permissible without exceeding the daily limit.

Preparation method (Oil Infusion): Pour 100 grams of dried and ground asafoetida gum with 300 milliliters of cold-pressed coconut oil. Infuse for 5 days at a temperature of 25–30 degrees Celsius, shaking periodically. Then heat in a water bath to 40 degrees Celsius and keep for 3 hours, avoiding boiling. Filter through double cheesecloth. Pour into dark glass dropper bottles.

Storage Conditions and Shelf Life (Oil Infusion): Store at a temperature of 5 to 20 degrees Celsius, in a dark place, away from sources of heat and electromagnetic radiation. After opening, use within 60 days. Total shelf life — 6 months.

Ointment — Asafoetida

Indications (Ointment): Spastic pain in the abdominal area, abdominal hypertonic symptoms, chronic bronchitis, cough with bronchospasm, inflammation of the lymph nodes, localized myalgia, arthralgia of rheumatoid nature, premenstrual pain syndrome, chronic pelvic pain, vulvodynia, neuropathic pain in the projection of the pelvic floor.

Standard Dosage (Ointment): Externally: apply a thin layer to the skin of the abdomen or chest 2 times a day, with light massaging movements until completely absorbed. Duration — up to 10 days.

Enhanced Dosage (Ointment): Externally: apply 3 times a day for pronounced pain syndromes: bronchospastic syndrome, pelvic pain, inflammation of the lymph nodes. Rub in for 5 minutes. Course — no more than 7 days.

Maximum Dosage (Ointment): Up to 4 applications per day, not exceeding a total daily dose of 12 grams of ointment. Used in conditions of resistant pelvic pain, neuroinflammatory syndromes, bronchospasm with frequent attacks.

Preventive Dosage (Ointment): Once a day on the epigastric or lower abdomen area — for chronic irritable bowel syndrome, premenstrual syndrome, tendency to bronchospasm during the cold season. Course — 14 days per month.

Pediatric Dosage (Ointment): From 5 years of age, with body weight from 18 kilograms — once a day apply to the chest or navel area, in a volume of no more than 0.5 grams. Used under adult supervision. Do not use on hypersensitive skin.

Contraindications (Ointment): Open skin damage, allergic dermatitis, individual intolerance to essential components, pustular skin lesions. No data on safety during pregnancy and lactation.

Side Effects (Ointment): Skin irritation, erythema, local itching, contact dermatitis. Occur when exceeding the dosage or when applying to damaged skin.

Adjustment for Patient Body Weight: With body weight less than 60 kilograms — use no more than 1 gram per application. With weight over 80 kilograms, an increase in dosage by 30% is allowed without exceeding the daily norm.

Preparation method (Ointment): For 100 grams of ointment: 10 grams of ground asafoetida gum, 80 grams of coconut oil, 10 grams of beeswax. Melt the wax in a water bath, add the oil, then add the asafoetida with constant stirring. Maintain the temperature not exceeding 45 degrees Celsius. Mix until a homogeneous mass is obtained, pour into sterile glass jars, cool at room temperature.

Storage Conditions and Shelf Life (Ointment): Store in a dark, cool place, at a temperature of 5 to 15 degrees Celsius. Avoid exposure to direct light and heating. Shelf life — up to 6 months. After opening, use within 30 days.

Paste — Asafoetida

Indications (Paste): Furunculosis, localized skin inflammations, abscessing processes, neurodermatitis, vulvodynia, local arthritis with a pronounced inflammatory component, itching of non-allergic nature, intercostal neuralgia, spastic pain in the lower abdominal segment, bronchospastic cough in children.

Standard Dosage (Paste): Externally: apply a thin layer to the affected area of skin 2 times a day, with or without a dry bandage, depending on the indications. Duration — up to 7 days.

Enhanced Dosage (Paste): Apply 3 times a day to inflamed skin areas or areas of local spasm. Used in the presence of a purulent focus, severe pain or a persistent inflammatory process.

Maximum Dosage (Paste): Up to 4 applications per day with a total mass of up to 20 grams of paste for furunculosis, acute abscesses, persistent pain in vulvodynia. Duration — no more than 3 days, then reduce the frequency of use.

Preventive Dosage (Paste): Once a day, volume up to 1 gram, on the epigastric or lower abdomen area. Used for chronic neurodermatitis, premenstrual pelvic pain, a tendency to intercostal neuralgia. Preventive course — 10 days per month.

Pediatric Dosage (Paste): From 3 years of age, with body weight from 15 kilograms — apply the size of a grain of rice once a day to the chest area for cough or the umbilical area for colic. Must be under adult supervision. Do not apply to damaged skin.

Contraindications (Paste): Purulent wounds with drainage, allergic dermatoses, weeping eczema, individual intolerance. Safety during pregnancy and lactation has not been established.

Side Effects (Paste): Redness, burning, itching, peeling of the skin at the application site. Occur when exceeding doses or applying to hypersensitive skin.

Adjustment for Patient Body Weight: For patients up to 60 kilograms — the volume of application should not exceed 2 grams. With weight above 80 kilograms — up to 4 grams at a time is permissible without exceeding the daily limit.

Preparation method (Paste): To prepare 100 grams: 25 grams of ground asafoetida gum, 50 grams of coconut oil, 25 grams of white clay (kaolin). Heat the oil to 40 degrees Celsius, gradually add asafoetida and clay, stirring thoroughly until a plastic mass is obtained. Cool and transfer to a porcelain or glass jar with a lid.

Storage Conditions and Shelf Life (Paste): Store in a tightly closed glass container at a temperature of 8 to 18 degrees Celsius, in a dark and dry place. Avoid overheating and light. Shelf life — up to 3 months. After opening, use within 30 days.

Cream — Asafoetida

Indications (Cream): Skin itching of neurogenic origin, skin irritation, localized dermatoses, dermatitis of the perianal area, periorbital edema of non-allergic nature, premenstrual skin manifestations, neurodermatitis, initial stage of rosacea, sensitive skin with impaired microcirculation.

Standard Dosage (Cream): Externally: apply a thin layer to cleansed skin 1–2 times a day, in the morning and evening. Volume — no more than 1 gram per application.

Enhanced Dosage (Cream): Apply 3 times a day to areas with pronounced hyperemia or itching, for acute forms of neurodermatitis, skin irritation, perioral and perianal dermatoses. Duration — no more than 5 days.

Maximum Dosage (Cream): Up to 4 applications per day, volume up to 6 grams per day. Used in conditions of resistant itching, prolonged skin inflammation, neurocirculatory disorders of the facial skin.

Preventive Dosage (Cream): Once a day at night, in an amount of 0.5–1 gram. Indicated for persons with sensitive skin prone to inflammation, women with pronounced PMS skin reactions, patients with mild forms of rosacea. Preventive course — 20 days per month.

Pediatric Dosage (Cream): From 4 years of age, with body weight from 16 kilograms — apply the size of a pea once a day, to areas with irritation or redness. Only externally and under adult supervision.

Contraindications (Cream): Acute purulent processes, atopic dermatitis in the acute phase, allergy to essential oils, weeping forms of eczema. No registered data on safety during pregnancy and lactation.

Side Effects (Cream): Redness, short-term burning, mild itching — mainly when applied to damaged skin or with hypersensitivity to components.

Adjustment for Patient Body Weight: Up to 60 kilograms — the dosage is reduced by 25%. Over 80 kilograms, an increase in dose by 30% is allowed without exceeding the daily norm.

Preparation method (Cream): For 100 grams: 5 grams of ground asafoetida gum, 50 grams of coconut oil, 30 grams of distilled water, 15 grams of natural emulsifier (e.g., beeswax with lecithin). Heat the oil and emulsifier in a water bath to 45 degrees Celsius, add asafoetida. Gradually add water with constant whipping. After reaching a creamy consistency, cool to room temperature, transfer to a sterile glass jar.

Storage Conditions and Shelf Life (Cream): Store in an airtight glass container at a temperature of 5 to 15 degrees Celsius, in the shade, without access to light. Do not freeze. Shelf life — up to 2 months. After opening, use within 21 days.

Cosmetic Serum — Asafoetida

Indications (Cosmetic Serum): Rosacea, telangiectasias, congestive skin hyperemia, dull complexion, impaired skin microcirculation, premenstrual vascular reactions, age-related vascular changes, chronic stress with autonomic manifestations on the skin, a tendency to vascular spots and edema.

Standard Dosage (Cosmetic Serum): Apply 2–3 drops to the face and neck once a day in the evening, on cleansed skin, before applying cream. Avoid the area around the eyes.

Enhanced Dosage (Cosmetic Serum): 3–5 drops twice a day for pronounced vascular pattern of the skin, episodic edema, "tired face" syndrome. Duration — up to 14 days, then switch to standard dosage.

Maximum Dosage (Cosmetic Serum): Up to 6 drops 2 times a day. Permissible for resistant forms of rosacea, intense perioral vascular spots, stress-induced hyperemia. No more than 10 days in a row.

Preventive Dosage (Cosmetic Serum): 1–2 drops on the face once a day, in the evening. Recommended for women with premenstrual vascular skin instability, patients over 40 years of age with sensitive skin. Course — 21 days per month, 7 days break.

Pediatric Dosage (Cosmetic Serum): Not used in children and adolescents under 16 years of age due to the lack of clinical testing of the cosmetic form in this age group.

Contraindications (Cosmetic Serum): Allergy to essential oils and resins, active phase of rosacea, skin microtraumas, dermatitis in the acute stage. Safety during pregnancy and lactation has not been scientifically established.

Side Effects (Cosmetic Serum): Mild tingling, hyperemia, feeling of heat, transient rash is possible when exceeding the dosage or with individual intolerance.

Adjustment for Patient Body Weight: Adjustment is not required — the dosage is determined solely by the area of application.

Preparation method (Cosmetic Serum): For 100 milliliters: 3 grams of dry asafoetida extract, 70 milliliters of distilled water, 20 milliliters of witch hazel hydrolate, 5 milliliters of vegetable glycerin, 2 milliliters of plant-based preservative (e.g., CO2 rosemary extract). The components are combined at a temperature of 25–30 degrees Celsius, thoroughly mixed in the emulsion phase. Pour into a glass bottle with a pipette. Do not use metal utensils.

Storage Conditions and Shelf Life (Cosmetic Serum): Store at a temperature of 5 to 15 degrees Celsius in a light-protected place. After opening, use within 30 days. Total shelf life — up to 3 months in the original sealed packaging.

Essential Oil — Asafoetida

Indications (Essential Oil): Bronchospastic syndrome, anxiety disorder, insomnia, autonomic dysfunction, tension headache, neurocirculatory dystonia, chronic fatigue syndrome, anxious depression, hyperexcitability, dysmenorrhea, premenstrual tension syndrome.

Standard Dosage (Essential Oil): Aromatherapy: 1–2 drops of essential oil in an aroma lamp per 15 m² of room, session — up to 30 minutes, once a day. Externally (as part of a carrier oil) — 1 drop per 5 milliliters of carrier oil, apply to the wrists, neck, solar plexus, 1–2 times a day.

Enhanced Dosage (Essential Oil): Up to 3 drops per session in an aroma lamp for severe forms of anxiety, panic attacks, persistent insomnia. Externally — up to 2 drops per 5 ml of carrier oil for pronounced nervous excitability and hormonal disorders. No more than 10 days.

Maximum Dosage (Essential Oil): 5 drops in an aroma diffuser for chronic fatigue syndrome and hyperexcitability, only in a well-ventilated room. Externally — no more than 3 drops per 5 ml of carrier oil for acute anxiety attacks, headache, premenstrual instability. Maximum 2 times a day.

Preventive Dosage (Essential Oil): 1 drop in an aroma pendant or on a cloth napkin, once a day. Indicated for patients with meteosensitivity, sleep onset disorders, autonomic instability. Course — 14 days, 7 days break.

Pediatric Dosage (Essential Oil): Used from 10 years of age, only in the form of aroma application: 1 drop for 20 minutes in an aroma lamp in a well-ventilated room. External use is not recommended for children under 14 years of age.

Contraindications (Essential Oil): Epilepsy, pregnancy, lactation, bronchial asthma, individual intolerance to essential oils. Not used in children under 10 years of age. Do not use on damaged skin.

Side Effects (Essential Oil): Headache, irritation of the nasal mucosa, increased anxiety, tachycardia — when exceeding permissible doses and duration of inhalation.

Adjustment for Patient Body Weight: Adjustment for external use: with body weight below 50 kilograms — no more than 1 drop per 10 milliliters of carrier oil. With weight above 80 kilograms — standard dilution of up to 2 drops per 5 milliliters of carrier oil is allowed.

Preparation method (Essential Oil): 100 grams of asafoetida gum are subjected to steam distillation for 3 hours at a temperature of 100 degrees Celsius. The collected essential oil is separated from the hydrolate and filtered through a paper filter. The yield is about 2–3 milliliters of oil with a characteristic pungent odor.

Storage Conditions and Shelf Life (Essential Oil): Store in a tightly sealed dark glass container at a temperature of 5 to 15 degrees Celsius, away from light and heat sources. Shelf life — up to 2 years. After opening, use within 3 months.

Toxicity and Biosafety of Asafoetida

Toxicity studies of asafoetida gum show a low level of acute toxicity upon oral and external use at therapeutic doses. According to preclinical animal studies, the LD₅₀ value for dry asafoetida extract upon oral administration in mice is 4,000 mg/kg body weight, which qualifies the substance as slightly toxic according to the WHO classification.

At the same time, in subchronic studies with long-term administration at doses up to 250 mg/kg, no significant histological changes in the tissues of the liver, kidneys and heart were detected. However, at doses exceeding 500 mg/kg, experimental animals showed mild irritation of the gastric mucosa and moderate changes in blood biochemical parameters, which indicates a potential load on the hepatobiliary system in case of overdose.

No data on mutagenicity and carcinogenicity of asafoetida gum at doses exceeding therapeutic doses have been registered. Modern data confirm the biosafety of short courses of use as part of herbal preparations, including in children over 5 years of age. However, with prolonged or uncontrolled use, accumulation of organic sulfur-containing components is possible, which can cause metabolic overload in persons with liver failure.

Reference: https://www.researchgate.net/p...

Pharmacodynamics — Asafoetida

Asafoetida gum has a complex pharmacodynamic profile due to the high content of organic sulfur-containing compounds (in particular, ferulic acid, umbelliferone, β-pinenes, as well as volatile essential components). Pharmacological activity is manifested both at the level of systemic regulation and at the level of local receptor interactions. Established biologically active substances act on target systems: nervous, immune, respiratory, digestive, endocrine and skin.

One of the key pharmacodynamic effects is central sedative and anxiolytic action, associated with increased GABAergic neurotransmission. The presence of lignans and coumarins in the gum, which interact with GABA receptors and modulate the function of benzodiazepine sites, determines the inhibitory effect on excitatory neural circuits. This is confirmed by a decrease in motor activity and a decrease in behavioral excitability in preclinical models. In parallel, the activity of lignans is manifested in the form of a weak spasmolytic effect, realized through the blockade of calcium channels of smooth muscle cells.

At the level of the digestive system, asafoetida exhibits carminative, anthelmintic and secretomodulatory properties. Essential oils and phenolic compounds stimulate the secretion of salivary and gastric glands, increase the peristalsis of the small intestine, reducing transit time and promoting gas evacuation. Sulfur-containing compounds act as local irritants of receptors of the mucous membrane of the stomach and intestines, which mediates a moderate prokinetic effect.

The gum contains components with proven antimicrobial and antiparasitic activity, including flavonoids and terpenes. Their effect is realized by inhibiting the activity of microbial enzymes and violating the integrity of pathogen membranes. Experimental models demonstrate a bacteriostatic effect against gram-positive and gram-negative strains, as well as activity against helminths, including impaired motor activity and cuticle structure of parasites.

Asafoetida has an anti-inflammatory effect at the systemic level, mediated by inhibition of the enzymes COX-2 and 5-LOX. This reduces the biosynthesis of pro-inflammatory mediators — prostaglandins and leukotrienes. The presence of ferulic acid derivatives also contributes to the suppression of the expression of interleukins (IL-1β, IL-6) and TNF-α, which is confirmed by in vitro and in vivo data. These effects are complemented by antioxidant activity, provided by phenolic groups capable of binding free radicals and restoring oxidized forms of lipids and proteins.

The immunomodulatory effect of asafoetida is realized through the effect on cytokine production and regulation of lymphocyte activity. Under conditions of chronic inflammation, a decrease in the production of pro-inflammatory cytokines and normalization of the Th1/Th2 ratio were detected. The effects have been experimentally confirmed when using extracts in cell cultures and models of immune activation.

Endocrine activity is expressed in the estrogen-like effect of some coumarins and phenolic compounds that interact with nuclear estrogen receptors. This is manifested in a change in the expression of hormone-sensitive genes and affects hormonal regulation in the reproductive system, which has been studied at the histological and biochemical levels in experimental works.

On the skin, essential oils have a local antiseptic and vasoregulatory effect, improving microcirculation, reducing congestion and reducing the severity of local inflammation. A number of works indicate the restoration of the skin barrier with external use, due to the inhibition of lipoperoxidase activity and normalization of glutathione levels.

Thus, the pharmacodynamics of asafoetida gum is a combination of multicomponent biochemical effects with systemic and local implementation. The effects cover a wide range of physiological targets: neurotransmitter receptors, membrane channels, inflammation enzymes and cytokine cascades.

References:
https://www.researchgate.net/p...
https://www.ncbi.nlm.nih.gov/p...
https://www.sciencedirect.com/...
https://pubchem.ncbi.nlm.nih.g...

Pharmacokinetics — Asafoetida

The pharmacokinetic properties of asafoetida gum are due to its complex composition, including sulfur-containing volatile components, phenolic compounds, flavonoids, terpenoids and coumarins. The main route of administration for most pharmacological forms is oral, and transdermal and inhalation routes are also used, less often — mucosal (through mucous membranes).

After oral administration, the active components undergo partial absorption in the upper parts of the gastrointestinal tract. Volatile sulfur-containing compounds and some terpenes begin to be absorbed already in the gastric mucosa, while flavonoids and phenolic acids are mainly absorbed in the small intestine with the participation of active transport and diffusion. Coumarin-like compounds can be metabolized already at the first stage of passage through the gastric mucosa and liver, which indicates a possible first-pass effect.

Transdermal administration (via ointments, pastes, creams and essential forms) depends on the lipophilicity of the molecules. Fractions with low molecular weight and high solubility in lipids easily penetrate through the stratum corneum of the skin. Especially pronounced percutaneous absorption is observed in areas with thin epidermis and increased vascularization (neck, abdomen, inner surface of the wrist). In this case, some compounds can be deposited in the subcutaneous adipose tissue, forming a slow release.

The inhalation route (using essential oil) ensures rapid entry of volatile fractions into the systemic circulation through the alveolar membrane. This allows achieving a rapid systemic reaction at a minimum dosage. The components of the esters undergo metabolic transformation in the liver and partially in the lung tissue, where they interact with microsomal enzymes.

After absorption, active substances are distributed mainly in organs with intense blood flow — the liver, kidneys, lungs, and partially in adipose tissue. Some flavonoids and coumarins are able to bind to plasma proteins, in particular albumin, and penetrate the blood-brain barrier, which explains the effect on the central nervous system.

The metabolism of active components occurs in the liver, with the participation of cytochrome P450 enzymes, glucuronyltransferases and sulfotransferases. The main pathways of biotransformation include hydroxylation, conjugation with glucuronic acid and sulfation. The conjugates are subsequently excreted in bile and urine. Sulfur-containing components, as well as their metabolites, can be partially excreted through the lungs and skin, which is confirmed by a persistent specific smell of the body and breath with prolonged use.

The intestinal microbiota also participates in the metabolism of a number of asafoetida components, especially with respect to phenolic and coumarin compounds. It has been established that certain strains of intestinal bacteria can enhance or weaken the pharmacological activity of metabolites.

Excretion of metabolites is carried out mainly by the kidneys — in the form of water-soluble conjugates of flavonoids and phenols, as well as through the intestines with bile — with respect to lipophilic metabolites of a terpenoid nature. Inactive components and residual essential fractions can also be partially excreted through the sweat glands and respiratory tract.

Thus, the pharmacokinetics of asafoetida is determined by a multi-stage process of absorption, distribution, biotransformation and excretion, in which the gastrointestinal tract, skin, liver, lungs, microflora and excretory systems are involved. The polyvalent nature of the gum substances provides a wide range of bioavailability in various forms and routes of administration.

References:
https://www.sciencedirect.com/...
https://www.ncbi.nlm.nih.gov/p...
https://pubchem.ncbi.nlm.nih.g...
https://www.researchgate.net/p...

Mechanisms of Action and Scientific Rationale — Asafoetida

Asafoetida resin contains biologically active substances, including organic sulfur-containing compounds, flavonoids, terpenoids, coumarins and phenolic acids, each of which demonstrates specific modulation of biological targets. One of the most studied mechanisms of action is the inhibition of inflammatory enzyme cascades, in particular cyclooxygenase-2 (COX-2) and 5-lipoxygenase (5-LOX), which leads to a decrease in the synthesis of prostaglandins and leukotrienes. This action is realized through phenolic and coumarin compounds capable of suppressing COX-2 expression at the mRNA level, as confirmed in an in vitro model of induced inflammation.

Additionally, it has been established that ferulic acid and umbelliferone isolated from the resin suppress the activation of the transcription factor NF-κB, which plays a key role in the regulation of pro-inflammatory cytokines such as TNF-α, IL-1β and IL-6. Suppression of NF-κB activity leads to a decrease in the expression of adhesion molecules in the vascular endothelium, limiting the influx of neutrophils and macrophages into the area of inflammation. This is confirmed by the results of cellular models and biochemical analyzes published in peer-reviewed journals.

The sedative and anxiolytic effect is explained by the influence of some resin components on the GABAergic system. Studies have shown that essential components can enhance the activity of GABA-A receptors through allosteric modulation, which reduces neuronal excitability and realizes a central inhibitory effect. A similar effect is observed upon interaction with benzodiazepine receptor sites. A decrease in the activity of the enzyme acetylcholinesterase (AChE) has also been recorded, which may be important for cognitive and autonomic regulatory functions.

Terpenoid and phenolic components affect the antioxidant defense of cells by activating the enzyme systems superoxide dismutase (SOD), catalase and glutathione peroxidase. At the same time, the formation of reactive oxygen species (ROS) is suppressed and the level of lipid peroxidation is reduced. This action is especially pronounced in models of oxidative stress in neurons and hepatocytes. Stimulation of these enzymes protects cell membranes and mitochondrial structures from damage.

The immunomodulatory potential is associated with an effect on the activity of macrophages and lymphocytes, as well as on the balance of cytokine production. A number of studies have demonstrated a decrease in the production of IL-4 and IL-6 while stabilizing the level of IFN-γ, which may indicate a normalization of the Th1/Th2 ratio. Some data indicate suppression of the activation of the JAK/STAT signaling pathway, which plays an important role in the regulation of immune and proliferative processes.

The activity of individual asafoetida components against microbial and parasitic structures has also been shown. Biological mechanisms include damage to the cell membrane of microorganisms, inhibition of protein and nucleic acid synthesis, as well as a decrease in the mobility of parasitic organisms. Some terpenes interact with microbial metabolic enzymes, disrupting their energy metabolism.

Thus, the pharmacological activity of asafoetida resin is realized through a wide range of biological targets, including inflammatory mediators, neurotransmitter receptors, enzyme and antioxidant systems, immune cells and signaling cascades. These mechanisms are confirmed by numerous preclinical studies and form the basis for its use in various therapeutic areas.

References:
https://www.ncbi.nlm.nih.gov/p...
https://www.sciencedirect.com/...
https://pubchem.ncbi.nlm.nih.g...
https://www.researchgate.net/p...

Synergy — Asafoetida

Pharmacological synergy of asafoetida resin with other natural and biologically active substances has been confirmed in a number of preclinical and laboratory studies, reflecting both additive and potentiating interactions. The most studied are combinations with plants containing flavonoids, terpenes and sulfhydryl groups, as well as interactions with components that have antimicrobial, spasmolytic and sedative activity.

At the level of anti-inflammatory activity, potentiation of the effect has been established with combined use with phenolic acids, in particular with gallic and rosmarinic acid. The combination leads to enhanced inhibition of the enzymes COX-2 and 5-LOX, as well as to suppression of IL-6 and TNF-α production against the background of active NF-κB suppression. This effect is due to different points of impact on the inflammatory cascade: asafoetida components affect transcription factors, while flavonoids from accompanying plants affect the enzymatic links of prostaglandin biosynthesis.

Inhibition of microbial and parasitic agents is enhanced when asafoetida resin is combined with substances that have a destructive effect on the cell wall or membrane of pathogens. Studies demonstrate synergy between asafoetida terpene compounds and sesquiterpenes of other plants, leading to destabilization of the lipid layer of pathogens and an increase in cell membrane permeability. This, in turn, is accompanied by activation of apoptosis mechanisms in microorganisms.

The sedative and anxiolytic potential of asafoetida is enhanced when combined with extracts containing lignans and isoflavones that act on GABA-A receptors and benzodiazepine modulator sites. This modulating effect has been confirmed in in vivo behavioral tests, where a significant decrease in motor activity was observed at lower doses of active substances in combination compared to monotherapy. The mechanism involves an increase in chlorine currents through the ion channels of GABA receptors due to allosteric stabilization of their open state.

The antioxidant activity of the resin is potentiated when combined with compounds that activate the transcription factor Nrf2, including some glycosides and flavonoids. Such interaction leads to synergistic induction of antioxidant defense enzymes: glutathione peroxidase, superoxide dismutase and glutathione-S-transferase. The result is enhanced suppression of lipid peroxidation and stabilization of membrane structures at the cellular level.

Immunomodulatory synergy between asafoetida coumarins and polysaccharides from other medicinal plants is noted, manifested in the normalization of cytokine production balance, a decrease in the expression of inflammatory markers and an increase in the phagocytic activity of macrophages. It is assumed that the combined effect on the JAK/STAT and MAPK signaling pathways provides complex regulation of the cellular immune response.

At the level of the intestinal microbiota, it has been proven that the combination of asafoetida resin with prebiotic oligosaccharides enhances the restoration of bacterial balance, which is mediated by the combined stimulation of the growth of lacto- and bifidobacteria, as well as a decrease in the production of pathogenic metabolites. This effect is considered as a component of systemic anti-inflammatory regulation through the gut-immunity axis.

Thus, the synergistic interactions of asafoetida resin cover a wide range of pharmacological areas, including neuromodulation, anti-inflammatory and antimicrobial effects, antioxidant protection, immune regulation and maintenance of microbial balance. The effects are realized through multiple receptor, enzyme and signaling targets, are experimentally confirmed and have a systemic nature.

References:
https://www.ncbi.nlm.nih.gov/p...
https://www.sciencedirect.com/...
https://www.researchgate.net/p...
https://pubmed.ncbi.nlm.nih.go...

Geography of Application and Folk Medicine – Asafoetida

Asafoetida has traditionally been used in medical, ritual, and culinary practices primarily in the regions of South Asia, the Middle East, and Central Asia. The main centers of ethno-medicinal use include India, Iran, Afghanistan, Tajikistan, Pakistan, Tibet, Nepal, and Uzbekistan. In these regions, asafoetida resin has been known as a enduring element of medical and ritual culture since ancient times.

On the Indian subcontinent, asafoetida (hing) is widely used in the Ayurvedic tradition. It is considered a "heating" and "purifying" substance capable of affecting the subtle energies of the body and removing internal blockages in the "channels" (srotas). It is used in the form of powder, fried in ghee, as part of complex oil extracts, as well as in the form of "cakes" and pastes applied to the body. In medico-ritual practice, asafoetida is added to oil mixtures for rubs used in preparation for childbirth or ritual purifications.In traditional Iranian medicine, asafoetida is known by the name "anguza" and was used in the form of fumigations, smokes, and tinctures. In classical Arabic herbal manuals and by Persian physicians of Avicenna's era, the resin is mentioned as an active component in rubs and oils employed within the holistic therapy of body and spirit.

On the Tibetan Plateau, asafoetida was included in medicinal powders and ritual incense blends. In the Tibetan medical tradition, it was classified among strongly scented purifying substances used for "dissolving the winds," restoring balance between energies of a "lunar" and "solar" nature, as well as for fumigating rooms. The smoke of asafoetida was used to expel disease-causing entities and as protection against "contaminated breath."

In Central Asia, including among the Uzbek, Tajik, and Turkmen peoples, asafoetida was used as a component of home medicinal remedies and carminative pills, often mixed with honey, flour, and animal fats. Furthermore, in folk culture, it was revered as a protective amulet — pieces of dried resin were carried in small bags on the belt or under clothing to protect against the "evil eye," illnesses, and spells.

In the Middle East, particularly among Bedouin and Persian tribes, asafoetida was burned on coals during rituals of exorcism or house cleansing. The aroma of the resin was considered unpleasant to evil entities while simultaneously connecting one to the world of ancestors. In some cultures, it was mixed with frankincense, myrrh, or sandalwood to form special ritual blends used in temples and places of solitude.

In the culture of ancient Egypt and the Eastern Mediterranean, there is also evidence of the use of resinous exudates, similar in composition to asafoetida, in the preparation of medicinal ointments and for treating bodies before mummification. References appear in the Ebers Papyrus, which describes fragrant resins used for "purifying the breath."

Among Afghan and Pashtun tribes, asafoetida was used as an element of natural food preservation and protection, as well as in ritual procedures for newborns. The resin was placed in the corners of the house or under the threshold to "keep health within the dwelling."

Thus, the geography of traditional asafoetida use spans a vast territory from the Eastern Mediterranean to the Himalayas. It was endowed not only with therapeutic properties but also with sacred functions — as a connecting substance between body, spirit, and space.